XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common stock
Retained earnings (deficit)
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2023   110,152,000    
Beginning balance at Dec. 31, 2023 $ 2,344,841 $ 1,707,471 $ 926,720 $ (289,350)
Increase (decrease) in stockholders' equity        
Net income (loss) for common stock 42,122   42,122  
Other comprehensive (loss) income, net of tax benefits (9,801)     (9,801)
Share-based expenses and other, net and Common stock offering (in shares)   151,000    
Share-based expenses and other, net 218 $ 218    
Ending balance (in shares) at Mar. 31, 2024   110,303,000    
Ending balance at Mar. 31, 2024 2,377,380 $ 1,707,689 968,842 (299,151)
Beginning balance (in shares) at Dec. 31, 2023   110,152,000    
Beginning balance at Dec. 31, 2023 2,344,841 $ 1,707,471 926,720 (289,350)
Increase (decrease) in stockholders' equity        
Other comprehensive (loss) income, net of tax benefits 31,153      
Ending balance (in shares) at Sep. 30, 2024   172,466,000    
Ending balance at Sep. 30, 2024 1,577,041 $ 2,266,282 (431,044) (258,197)
Beginning balance (in shares) at Mar. 31, 2024   110,303,000    
Beginning balance at Mar. 31, 2024 2,377,380 $ 1,707,689 968,842 (299,151)
Increase (decrease) in stockholders' equity        
Net income (loss) for common stock (1,295,484)   (1,295,484)  
Other comprehensive (loss) income, net of tax benefits 1,594     1,594
Share-based expenses and other, net 1,783 $ 1,783    
Ending balance (in shares) at Jun. 30, 2024   110,303,000    
Ending balance at Jun. 30, 2024 1,085,273 $ 1,709,472 (326,642) (297,557)
Increase (decrease) in stockholders' equity        
Net income (loss) for common stock (104,402)   (104,402)  
Other comprehensive (loss) income, net of tax benefits 39,360     39,360
Share-based expenses and other, net and Common stock offering (in shares)   62,163,000    
Common stock offering 575,000 $ 575,000    
Share-based expenses and other, net (18,190) $ (18,190)    
Ending balance (in shares) at Sep. 30, 2024   172,466,000    
Ending balance at Sep. 30, 2024 $ 1,577,041 $ 2,266,282 (431,044) (258,197)
Beginning balance (in shares) at Dec. 31, 2024 172,465,608 172,466,000    
Beginning balance at Dec. 31, 2024 $ 1,479,089 $ 2,264,544 (788,916) 3,461
Increase (decrease) in stockholders' equity        
Net income (loss) for common stock 26,671   26,671  
Other comprehensive (loss) income, net of tax benefits (460)     (460)
Share-based expenses and other, net and Common stock offering (in shares)   28,000    
Share-based expenses and other, net 576 $ 576    
Ending balance (in shares) at Mar. 31, 2025   172,494,000    
Ending balance at Mar. 31, 2025 $ 1,505,876 $ 2,265,120 (762,245) 3,001
Beginning balance (in shares) at Dec. 31, 2024 172,465,608 172,466,000    
Beginning balance at Dec. 31, 2024 $ 1,479,089 $ 2,264,544 (788,916) 3,461
Increase (decrease) in stockholders' equity        
Other comprehensive (loss) income, net of tax benefits $ (1,500)      
Ending balance (in shares) at Sep. 30, 2025 172,620,476 172,620,000    
Ending balance at Sep. 30, 2025 $ 1,563,836 $ 2,267,288 (705,413) 1,961
Beginning balance (in shares) at Mar. 31, 2025   172,494,000    
Beginning balance at Mar. 31, 2025 1,505,876 $ 2,265,120 (762,245) 3,001
Increase (decrease) in stockholders' equity        
Net income (loss) for common stock 26,085   26,085  
Other comprehensive (loss) income, net of tax benefits (306)     (306)
Share-based expenses and other, net and Common stock offering (in shares)   118,000    
Share-based expenses and other, net 2,777 $ 2,777    
Ending balance (in shares) at Jun. 30, 2025   172,612,000    
Ending balance at Jun. 30, 2025 1,534,432 $ 2,267,897 (736,160) 2,695
Increase (decrease) in stockholders' equity        
Net income (loss) for common stock 30,747   30,747  
Other comprehensive (loss) income, net of tax benefits (734)     (734)
Share-based expenses and other, net and Common stock offering (in shares)   8,000    
Share-based expenses and other, net $ (609) $ (609)    
Ending balance (in shares) at Sep. 30, 2025 172,620,476 172,620,000    
Ending balance at Sep. 30, 2025 $ 1,563,836 $ 2,267,288 $ (705,413) $ 1,961